Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis. Signoriello E, Lanzillo R, Brescia Morra V, Di Iorio G, Fratta M, Carotenuto A, Lus G Mult Scler. 2015 Oct 9. PMID: 26453682. Abstract CommentRecommendBookmarkWatch